Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Current Drug Therapy

  • You have access
    Adrenergic receptors: structure and function
    Robert M. Graham, MD
    Cleveland Clinic Journal of Medicine July 1990, 57 (5) 481-491;

    Our understanding of adrenergic receptors is a result of studies of structure and function that involve classical biochemistry and pharmacology as well as recombinant DNA technology.

  • You have access
    Adenosine: a new drug for acute termination of supraventricular tachycardia
    Sergio L. Pinski, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine June 1990, 57 (4) 383-388;
  • You have access
    Alternate delivery methods for morphine sulfate in cancer pain
    Kirk V. Shepard, MD and Alan W. Bakst, RPH, PHARMD
    Cleveland Clinic Journal of Medicine January 1990, 57 (1) 48-52;
  • You have access
    Anticonvulsants for treatment of manic depression
    Gustavo A. Delucchi, MD and Joseph R. Calabrese, MD
    Cleveland Clinic Journal of Medicine November 1989, 56 (8) 756-761;
  • You have access
    Thrombolytic therapy
    James H. Stewart, MD, Jeffrey W. Olin, DO and Robert A. Graor, MD
    Cleveland Clinic Journal of Medicine May 1989, 56 (3) 290-296;
  • You have access
    Thrombolytic therapy
    James H. Stewart, MD, Jeffrey W. Olin, DO and Robert A. Graor, MD
    Cleveland Clinic Journal of Medicine March 1989, 56 (2) 189-196;
  • You have access
    Nonsteroidal anti-inflammatory drug therapy
    Daniel J. Mazanec, MD
    Cleveland Clinic Journal of Medicine September 1988, 55 (5) 419-425;

Pages

  • Previous
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire